not tagged
abbvie
['lymphoma', 'abbvie']
during the presidential symposium at #eha2022, in collaboration with , we presented late-breaking data from our investigational phase 2 trial in patients with relapsed/refractory large b-cell lymphoma (#lbcl). learn more: 
AbbVie's global handle featuring biopharmaceutical news & updates managed by our corp digital team. Review our guidelines: https://t.co/RJsgPRX3Cb…